Development Level

Tbio 2 | 10,625
Tclin 1 | 602

IMPC Term

abnormal behavior 1 | 226
abnormal tooth morphology 1 | 24
absent teeth 1 | 4
increased circulating sodium l... 1 | 71

Disease

Alzheimer's disease 2 | 644
Hyperactive behavior 2 | 31
Obesity 2 | 616
Parkinson's disease 2 | 364
Schizophrenia 2 | 503
diabetes mellitus 2 | 1,663
lung cancer 2 | 4,473
osteosarcoma 2 | 7,933
Alcohol dependence 1 | 107
Amphetamine-Related Disorders 1 | 74
Anxiety Disorders 1 | 37
Attention deficit hyperactivity disorder 1 | 156
Autism spectrum disorder 1 | 17
Binge eating disorder 1 | 3
Bipolar Disorder 1 | 266
Bradycardia 1 | 24
Brain disease 1 | 84
Cancer 1 | 2,346
Catalepsy 1 | 15
Cocaine dependence 1 | 24
Cocaine-Related Disorders 1 | 88
Conduct disorder 1 | 25
Dementia 1 | 129
Depressive disorder 1 | 48
Diarrhea 1 | 155
Dumping syndrome 1 | 9
Duodenal ulcer 1 | 20
Dystonia 1 | 77
Gilles de la Tourette syndrome 1 | 47
Heroin dependence 1 | 30
Local anesthesia 1 | 40
MAJOR AFFECTIVE DISORDER 1 1 | 2
Major Depressive Disorder 1 | 106
Memory Disorders 1 | 36
Micronuclei, Chromosome-Defective 1 | 20
Multiple system atrophy 1 | 27
Muscle Rigidity 1 | 5
Narcolepsy 1 | 69
Nerve Degeneration 1 | 73
Neurodegenerative disease 1 | 383
Nicotine dependence 1 | 53
Oppositional defiant disorder 1 | 16
Oropouche fever 1 | 2
Pain agnosia 1 | 99
Paranoia 1 | 8
Parkinson Disease 1 | 105
Parkinsonism-Dystonia, Infantile 1 | 1
Parkinsonism-dystonia infantile 1 | 1
Pathological gambling 1 | 16
Psychoses, Substance-Induced 1 | 17
REM sleep behavior disorder 1 | 16
Restless legs syndrome 1 | 28
Seasonal affective disorder 1 | 25
Secondary Parkinson Disease 1 | 9
Sleepiness Due To Obstructive Sleep Apnea 1 | 1
Sleepiness Due To Shift Work Sleep Disorder 1 | 1
Smoking cessation assistance 1 | 8
Steatorrhea 1 | 20
Substance abuse 1 | 55
TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) 1 | 12
Tic disorder 1 | 3
Tooth erosion 1 | 5
Toxic encephalopathy 1 | 131
atypical teratoid / rhabdoid tumor 1 | 4,369
group 4 medulloblastoma 1 | 1,875
head and neck cancer 1 | 270
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
malignant mesothelioma 1 | 3,163
nervous system disorder 1 | 53
non-small cell lung cancer 1 | 2,798
obsessive-compulsive disorder 1 | 34
ovarian cancer 1 | 8,492
pituitary cancer 1 | 1,972
posterior fossa group B ependymoma 1 | 1,530
primitive neuroectodermal tumor 1 | 3,031
psoriasis 1 | 6,685

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444

Target Family

Non-IDG 2 | 11,969
Transporter 1 | 473

Grant Application

5R03MH061000-02 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Neurotensin/neuromedin N NTS Tbio Non-IDG -3.54673 3485.1 161
Sodium-dependent dopamine transporter SLC6A3 Tclin Transporter -3.57190 3495.1 271
Tuftelin-interacting protein 11 TFIP11 Tbio Non-IDG -1.74071 62.9 73